284 related articles for article (PubMed ID: 24764226)
1. Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer.
Rodríguez M; Silva J; López-Alfonso A; López-Muñiz MB; Peña C; Domínguez G; García JM; López-Gónzalez A; Méndez M; Provencio M; García V; Bonilla F
Genes Chromosomes Cancer; 2014 Sep; 53(9):713-24. PubMed ID: 24764226
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study.
Kim JE; Eom JS; Kim WY; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Kim MH
Thorac Cancer; 2018 Aug; 9(8):911-915. PubMed ID: 29806739
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC).
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():123-35. PubMed ID: 9337531
[TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNA: a diagnostic marker for lung cancer.
Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
[TBL] [Abstract][Full Text] [Related]
5. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
6. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
7. [Plasminogen activator inhibitor type 1 (PAI-1) in blood and tissue extracts of patients with non-small cell lung cancer].
Zekanowska E; Cieśliński K; Rość D
Pneumonol Alergol Pol; 2004; 72(9-10):409-14. PubMed ID: 16021996
[TBL] [Abstract][Full Text] [Related]
8. Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL.
Georgiades G; Myrianthefs P; Venetsanou K; Kythreoti A; Kyroudi A; Kittas C; Baltopoulos G
Lung; 2003; 181(1):35-47. PubMed ID: 12879338
[TBL] [Abstract][Full Text] [Related]
9. Soluble Human Leukocyte Antigen-G in the Bronchoalveolar Lavage of Lung Cancer Patients.
Montilla D; Pérez M; Borges L; Bianchi G; Cova JA
Arch Bronconeumol; 2016 Aug; 52(8):420-4. PubMed ID: 27004472
[TBL] [Abstract][Full Text] [Related]
10. Exosome-derived miRNAs and ovarian carcinoma progression.
Vaksman O; Tropé C; Davidson B; Reich R
Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
[TBL] [Abstract][Full Text] [Related]
11. Identification of serum proteome components associated with progression of non-small cell lung cancer.
Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
[TBL] [Abstract][Full Text] [Related]
12. IL-2 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) patients.
Chyczewska E; Mróz RM; Kowal E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():136-45. PubMed ID: 9337532
[TBL] [Abstract][Full Text] [Related]
13. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
14. Isolation of the opioid peptide Leu-Val-Val-hemorphin-7 from bronchoalveolar lavage fluid of a patient with non-small cell lung cancer.
Duethman D; Dewan N; Conlon JM
Peptides; 2000 Jan; 21(1):137-42. PubMed ID: 10704729
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
16. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
[TBL] [Abstract][Full Text] [Related]
18. No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People.
Tian F; Shen Y; Chen Z; Li R; Ge Q
Biomed Res Int; 2017; 2017():1304816. PubMed ID: 28656135
[TBL] [Abstract][Full Text] [Related]
19. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.
Li QK; Shah P; Li Y; Aiyetan PO; Chen J; Yung R; Molena D; Gabrielson E; Askin F; Chan DW; Zhang H
J Proteome Res; 2013 Aug; 12(8):3689-96. PubMed ID: 23802180
[TBL] [Abstract][Full Text] [Related]
20. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]